| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated fibroblasts in muscle sarcoidosis revealed by [18F]FAPI-74 PET
|
Watabe, Tadashi
|
|
|
50 |
11 |
p. 3481-3482
|
artikel
|
| 2 |
An antibody-radionuclide conjugate targets fibroblast activation protein for cancer therapy
|
Xu, Mengxin
|
|
|
50 |
11 |
p. 3214-3224
|
artikel
|
| 3 |
A reflection on journal rankings
|
Chiti, Arturo
|
|
|
50 |
11 |
p. 3164-3165
|
artikel
|
| 4 |
Collection on molecular imaging in neurodegeneration
|
Xie, Fang
|
|
|
50 |
11 |
p. 3166-3167
|
artikel
|
| 5 |
Dania Tamimi (Editor) Specialty imaging: Temporomandibular Joint and Sleep-Disordered Breathing, 2nd Edition
|
Mansi, Luigi
|
|
|
50 |
11 |
p. 3161-3162
|
artikel
|
| 6 |
Debating the future of nuclear medicine in the light of hybrid imaging applications
|
Georgoulias, Panagiotis
|
|
|
50 |
11 |
p. 3188-3189
|
artikel
|
| 7 |
[18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma
|
Zhu, Ziyuan
|
|
|
50 |
11 |
p. 3425-3438
|
artikel
|
| 8 |
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
|
Oprea-Lager, Daniela-Elena
|
|
|
50 |
11 |
p. 3439-3451
|
artikel
|
| 9 |
[18F]DPA-714: Effect of co-medications, age, sex, BMI and TSPO polymorphism on the human plasma input function
|
Peyronneau, MA
|
|
|
50 |
11 |
p. 3251-3264
|
artikel
|
| 10 |
[18F]FDG PET/CT advanced imaging in crucial management steps of a child affected by hypoplastic left heart syndrome
|
Pizzoferro, Milena
|
|
|
50 |
11 |
p. 3475-3476
|
artikel
|
| 11 |
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [18F]FDG-PET/CT
|
Enke, Johanna S.
|
|
|
50 |
11 |
p. 3479-3480
|
artikel
|
| 12 |
Highlights of the 35th EANM Annual Congress 2022, onsite edition in Barcelona, Spain: “FROM BARCELONA WITH LOVE”
|
Albert, Nathalie L.
|
|
|
50 |
11 |
p. 3168-3176
|
artikel
|
| 13 |
How to combine CTA, 99mTc-WBC SPECT/CT, and [18F]FDG PET/CT in patients with suspected abdominal vascular endograft infections?
|
Lauri, Chiara
|
|
|
50 |
11 |
p. 3235-3250
|
artikel
|
| 14 |
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy
|
Banerjee, Rahul
|
|
|
50 |
11 |
p. 3349-3353
|
artikel
|
| 15 |
ImmunoPET imaging–based pharmacokinetic profiles of an antibody and its Fab targeting endothelin A receptors on glioblastoma stem cells in a preclinical orthotopic model
|
Hautiere, Marie
|
|
|
50 |
11 |
p. 3192-3201
|
artikel
|
| 16 |
Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies
|
Dimitrakopoulou-Strauss, Antonia
|
|
|
50 |
11 |
p. 3354-3362
|
artikel
|
| 17 |
99mTc-Tilmanocept performance for sentinel node mapping in breast cancer, melanoma, and head and neck cancer: a systematic review and meta-analysis from a European expert panel
|
Rovera, Guido
|
|
|
50 |
11 |
p. 3375-3389
|
artikel
|
| 18 |
Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
|
Unterrainer, Marcus
|
|
|
50 |
11 |
p. 3390-3399
|
artikel
|
| 19 |
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
|
Schiebler, Tassilo
|
|
|
50 |
11 |
p. 3302-3312
|
artikel
|
| 20 |
Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [18F]-labeled glycopeptide-containing FAPI with [18F]FAPI-42
|
Huang, Jiawen
|
|
|
50 |
11 |
p. 3363-3374
|
artikel
|
| 21 |
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
|
Taprogge, Jan
|
|
|
50 |
11 |
p. 3225-3234
|
artikel
|
| 22 |
Not all black colons on [18F]FDG PET are due to metformin
|
Boeckxstaens, Lennert
|
|
|
50 |
11 |
p. 3477-3478
|
artikel
|
| 23 |
Occipital hypometabolism is a risk factor for conversion to Parkinson’s disease in isolated REM sleep behaviour disorder
|
Carli, Giulia
|
|
|
50 |
11 |
p. 3290-3301
|
artikel
|
| 24 |
Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics
|
Müller, Cristina
|
|
|
50 |
11 |
p. 3181-3184
|
artikel
|
| 25 |
Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients
|
Wang, DaQuan
|
|
|
50 |
11 |
p. 3400-3413
|
artikel
|
| 26 |
PET imaging of new target CDK19 in prostate cancer
|
Dai, Dong
|
|
|
50 |
11 |
p. 3452-3464
|
artikel
|
| 27 |
PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma
|
Lee, Zhenghong
|
|
|
50 |
11 |
p. 3190-3191
|
artikel
|
| 28 |
Prognostic value of imaging-based ATN profiles in a memory clinic cohort
|
Peretti, Débora E.
|
|
|
50 |
11 |
p. 3313-3323
|
artikel
|
| 29 |
Stephen Kralik, Nilesh Desai, Avner Meoded, Thierry Huisman (Authors). Fetal, Neonatal and Pediatric Neuroradiology
|
Mansi, Luigi
|
|
|
50 |
11 |
p. 3163
|
artikel
|
| 30 |
Superiority of [68Ga]Ga-DOTA-FAPI-04 PET/CT to [18F]FDG PET/CT in the evaluation of thymic epithelial tumours
|
Shen, Xiuling
|
|
|
50 |
11 |
p. 3414-3424
|
artikel
|
| 31 |
SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
|
Hartrampf, Philipp E.
|
|
|
50 |
11 |
p. 3465-3474
|
artikel
|
| 32 |
The EANM guideline on radioiodine therapy of benign thyroid disease
|
Campennì, Alfredo
|
|
|
50 |
11 |
p. 3324-3348
|
artikel
|
| 33 |
The future of atherosclerosis assessment: dynamic and quantitative whole-body PET cardiovascular imaging
|
Caobelli, Federico
|
|
|
50 |
11 |
p. 3177-3180
|
artikel
|
| 34 |
Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature
|
Escudero-Castellanos, Alondra
|
|
|
50 |
11 |
p. 3202-3213
|
artikel
|
| 35 |
Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
|
Quattrini, Giulia
|
|
|
50 |
11 |
p. 3265-3275
|
artikel
|
| 36 |
Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods
|
Jovalekic, Aleksandar
|
|
|
50 |
11 |
p. 3276-3289
|
artikel
|
| 37 |
Why does PSMA PET improve quality of life?
|
Evangelista, Laura
|
|
|
50 |
11 |
p. 3185-3187
|
artikel
|
Tijdschrift beschrijving